Table 1.
Demographic and Clinical Characteristics of 9,229 Patients Enrolled in Care in 6 Clinical Care Centersa Participating in the Caribbean, Central and South America Network for HIV Epidemiology, 2000–2014
Characteristic | Argentina (n = 1,636) |
Brazil (n = 2,008) |
Chile (n = 1,415) |
Honduras (n = 777) |
Mexico (n = 786) |
Peru (n = 2,607) |
All Sites (n = 9,229) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | |
Age, yearsb | 36 (30–44) | 34 (28–42) | 34 (28–41) | 36 (30–43) | 33(28–41) | 33 (27–41) | 34 (28–42) | |||||||
Male sex | 1,175 | 72 | 1,435 | 71 | 1,281 | 91 | 433 | 56 | 702 | 89 | 1,926 | 74 | 6,952 | 75 |
CD4 at enrollment, cells/uLb | 214 (81–366) | 292 (104–507) | 267 (96–453) | 123 (58–205) | 142 (43–309) | 156 (54–324) | 198 (68–81) | |||||||
AIDSc | 353 | 22 | 562 | 28 | 355 | 25 | 291 | 37 | 432 | 55 | 948 | 36 | 2,941 | 32 |
AIDS or CD4 of <200 | 816 | 50 | 888 | 44 | 625 | 44 | 621 | 80 | 560 | 71 | 1,652 | 63 | 5,162 | 56 |
AIDS or CD4 of <350 | 1,197 | 73 | 1,215 | 61 | 896 | 63 | 738 | 95 | 664 | 84 | 2,087 | 80 | 6,797 | 74 |
Transmission route | ||||||||||||||
Heterosexual | 647 | 40 | 920 | 46 | 322 | 23 | 456 | 59 | 225 | 29 | 1,590 | 61 | 4,160 | 45 |
Homosexual | 486 | 30 | 772 | 38 | 1,083 | 77 | 64 | 8 | 523 | 67 | 987 | 38 | 3,915 | 42 |
Other | 115 | 7 | 33 | 2 | 5 | <1 | 2 | <1 | 17 | 2 | 23 | 1 | 195 | 2 |
Unknown | 388 | 24 | 283 | 14 | 5 | <1 | 255 | 33 | 21 | 3 | 7 | <1 | 959 | 10 |
Lost to follow-up | 625 | 38 | 174 | 9 | 187 | 13 | 152 | 19 | 106 | 13 | 473 | 18 | 1,717 | 19 |
Abbreviations: AIDS, acquired immune deficiency syndrome; HIV, human immunodeficiency virus; IQR, interquartile range.
a Characteristics for patients included in the analysis according to site of enrollment in the Caribbean, Central and South America network for HIV epidemiology cohort.
b Values are expressed as median (IQR).
c AIDS was defined using Centers for Disease Control and Prevention (category C) or World Health Organization (stage 4) criteria.